350 results about "Polycyclic compound" patented technology

Provided are a polycyclic compound of a compound having such a structure that two benzene rings bond to a central benzene ring each other to form a fused ring and another fused ring bonds to a terminal thereof, and an organic electroluminescence device including one or more organic thin film layers containing a light emitting layer between a cathode and an anode, in which at least one of the organic thin film layers includes the polycyclic compound of the present invention. The organic electroluminescence device has high luminous efficiency, no defect in pixels, and long lifetime. In addition, provided is a polycyclic compound realizing the organic electroluminescence device.

The present invention provides a stable new condensed polycyclic compound which is not likely to form a molecular association. In addition, the present invention also provides an organic light-emitting element having a high light-emitting efficiency and a low drive voltage. In the condensed polycyclic compound in Claim 1 represented by the general formula [1], R1, R2 and R5 are each independently selected from a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an aryl group, and a heterocyclic group. R3 and R4 each represent an alkyl group having 1 to 4 carbon atoms. The aryl group and the heterocyclic group each may have at least one of an alkyl group, an aralkyl group, an aryl group, a heterocyclic group, an amino group, and an alkoxy group as a substituent.

By providing a novel polycyclic aromatic compound in which a plurality of aromatic rings are linked via a boron atom, a nitrogen atom, or the like, options of a material for an organic EL element are increased. In addition, by using the novel polycyclic aromatic compound as a material for an organic electroluminescent element, an excellent organic EL element is provided.

This invention relates to multicyclic compounds, pharmaceutical compositions comprising them, and methods of their use in, for example, the treatment of cognitive disorders.

New anionic surfactants and methods of preparation which are derived from aromatic or substituted aromatic molecules and alkenesulfonic acid. Wherein the aryl compound is alkylated and sulfonated in one-step with an alkene sulfonic acid prior to sulfonic acid neutralization. The methods allow the functional sulfonate group to be attached to the end of the alkyl chain rather than to the aromatic ring thus allowing for selective substituted groups, either branched, linear or alkoxylated or combinations thereof to be placed on the aryl compound prior to sulfonation and alkylation. The invention uses the alkene sulfonic acid produced from thin-film sulfonation of an alpha-olefin to alkylate benzene, mono-substituted aromatic, poly-substituted aromatic, alkylbenzene, alkoxylated benzene, polycyclic aromatic, mono-substituted polycyclic aromatic, poly-substituted polycyclic aromatic, naphthalene, alkylnaphthalene, phenol, alkylphenol, alkoxylated phenol, and alkoxylated alkylphenolalkyl substituted or polysubstituted cyclic or polycyclic compounds to produce the corresponding sulfonic acid having an additional alkyl group derived from the alpha-olefin used during the thin-film sulfonation which is either linear or branched.

PCT No. PCT/JP96/03300 Sec. 371 Date Jul. 10, 1997 Sec. 102(e) Date Jul. 10, 1997 PCT Filed Nov. 11, 1996 PCT Pub. No. WO97/17415 PCT Pub. Date May 15, 1997The present invention provides a guest-host liquid-crystal composition comprising a host liquid-crystal composition containing one or more dichroic dyes, characterized in that the host liquid-crystal composition comprises as the main component a polycyclic compound having three or more rings and having no cyano group in the direction of the molecular axis, the proportion of the polycyclic compound component having three or more rings in the host liquid-crystal composition being 75% by mole or higher, and that the guest-host liquid-crystal composition has an order parameter (S value) of 0.76 or higher. The invention further provides a liquid-crystal display element employing the composition. This guest-host liquid-crystal composition shows excellent dichroism or a high order parameter.

Disclosed is a polycyclic compound having a structure wherein two benzene rings are so bonded to a central benzene ring as to form a condensed ring to an end of which another condensed ring is bonded. Also disclosed is an organic electroluminescent device having one or more organic thin film layers including a light-emitting layer between a cathode and an anode, wherein at least one of the organic thin film layers contains the polycyclic compound. The organic electroluminescent device has high luminous efficiency, no pixel defects, and long life. The polycyclic compound enables realization of such an organic electroluminescent device.

The present invention relates to a method for the preparation of a layer of a plasma-polymerised material on the surface of a substrate, e.g. a substrate of a glass, an organosiloxane-based or polysiloxane-based material, silicon, fluoro-polymer (e.g. Teflon®), etc. The present invention also relates to novel objects and microstructured or micro-patterned devices, e.g. by lift-off techniques, in particular such objects and devices that have layers of electrically conducting materials providing a conductivity of at least 0.01 S/cm. A feature of the invention is the plasma-polymerization of a compound including at least one polycyclic compound, said polycyclic compound(s) comprising a non-aromatic heterocyclic ring fused to an aromatic or heteroaromatic ring or ring system. Examples of such compounds are 3,4-ethylenedioxythiophene (EDT) forming layers of poly(ethylenedioxythiophene) (PEDT), and piperonylamine, piperonyloyl chloride, safrole, 3,4-ethylenedioxypyrrole, 3,4-ethylenedioxy-N-methylpyrrole, and 3,4-methylenedioxythiophene.

A new condensed polycyclic compound represented by general formula [I]:

wherein R₁ is hydrogen, halogen, cyano, a substituted amino or a group selected from the group consisting of alkyl, aralkyl, aryl, heterocyclic, each having no substituent or a substituent; and Ar₁ to Ar₅ are the same or different and are each independently a condensed polycyclic aromatic group or a condensed polycyclic heterocyclic group, each having no substituent or a substituent is used for an organic light-emitting device that is extremely efficient in a light output with high luminance and is extremely durable.

An electrically conducting organic compound comprising a condensed polycyclic aromatic compound containing from 8 to 14 condensed rings and being solubilized in a solvent by the introduction of a functional group into any condensed ring of the compound. The electrically conducting organic compound is used as a constituent element in the production of electronic devices.

Disclosed is a polycyclic compound having a p-conjugated heteroacene skeleton crosslinked via a carbon atom, a nitrogen atom, an oxygen atom or a sulfur atom. Also disclosed is a halogen compound which can be used for the synthesis of the polycyclic compound. Further disclosed is an organic electroluminescence element which comprises a cathode, an anode, and at least one organic thin film layer containing a light-emitting layer and arranged between the cathode and the anode, wherein at least one layer in the organic thin film layer comprises a material for the organic electroluminescence element. The organic electroluminescence element has high luminous efficiency and has long service-life. The polycyclic compound can be used for the production of the organic electroluminescence element. The halogen compound is an intermediate for the polycyclic compound.

The invention provides a polycyclic pyridone compound as well as pharmaceutical composition and an application thereof. Specifically, the polycyclic pyridone compound is a compound shown as the formula (I) or pharmaceutically acceptable salt, solvate or hydrate of the compound. The compound can be used for preparing drugs for preventing or treating infectious diseases of mammals, and is particularly used for preparing drugs for preventing, treating, relieving and/or treating orthomyxovirus infection such as influenza A virus, influenza B virus and influenza C virus.

The invention relates to a new compound and an organic electroluminescent device containing the compound. The structural formula of the compound is shown as below, Ar₁ and Ar₂ are respectively and independently selected from substituted or unsubstituted aromatic group, aromatic ethylene group, polycyclic aromatic group, polycyclic aromatic ethylene group, aromatic amine group and a polycyclic compound containing nitrogen atoms or a heterocyclic compound containing nitrogen atoms. The invention resolves the problems existing in the colorimetric purity, luminescent efficiency, etc. of the currently used luminescent materials. The material of the invention can be used as a luminescent material, and the electroluminescent device prepared of the material of the invention has the predominant performances of high colorimetric purity, high brightness and high efficiency.

The invention provides a deuterium-substituted polycyclic pyridone compound, a prodrug thereof, a composition containing the compound and application of the composition. The deuterium-substituted polycyclic pyridone compound is the compound shown in the formula (I) or a tautomer, stereoisomer, prodrug, crystalline form, pharmaceutically acceptable salt, hydrate or solvent compound thereof. The compound and the composition show the cap-dependent endonuclease inhibitory activity and have superior pharmacokinetic properties.

A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, one or more bridged polycyclic compounds may be applied to an topical surface and/or an otic surface of an animal (e.g., canine, feline) such that an topical malady and/or otic malady may be inhibited and/or ameliorated.

Disclosed is an organic electroluminescent device (organic EL device) that is improved in luminous efficiency, sufficiently secures driving stability, and has a simple configuration. This organic EL device has a light-emitting layer between an anode and a cathode piled one upon another on a substrate and the said light-emitting layer contains a fused polycyclic compound in which seven or more rings are fused together as a host material. The aforementioned fused polycyclic compound has a structure formed by fusing two or more indole rings to a carbazole ring. A specific example thereof is the compound represented by the following formula.